Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2008 | 2 |
2009 | 1 |
2010 | 1 |
2012 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study.
Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):136-42. doi: 10.1177/2048872612447069.
Eur Heart J Acute Cardiovasc Care. 2012.
PMID: 24062901
Free PMC article.
Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial.
Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators.
Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators.
Lancet. 2006 Feb 18;367(9510):569-78. doi: 10.1016/S0140-6736(06)68147-6.
Lancet. 2006.
PMID: 16488800
Clinical Trial.
Item in Clipboard
Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy.
McDonald MA, Fu Y, Zeymer U, Wagner G, Goodman SG, Ross A, Granger CB, Van de Werf F, Armstrong PW; ASSENT-4 PCI Investigators.
McDonald MA, et al.
Eur Heart J. 2008 Apr;29(7):871-9. doi: 10.1093/eurheartj/ehn078. Epub 2008 Mar 4.
Eur Heart J. 2008.
PMID: 18319519
Clinical Trial.
Item in Clipboard
Reperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pre-treatment with full-dose fibrinolysis.
Sinnaeve PR, Ezekowitz JA, Bogaerts K, Droogne W, Jarai R, Huber K, Granger CB, Desmet WJ, Armstrong PW, Van de Werf FJ; ASSENT-4 PCI Investigators.
Sinnaeve PR, et al.
Eur Heart J. 2009 Sep;30(18):2213-9. doi: 10.1093/eurheartj/ehp246. Epub 2009 Jul 8.
Eur Heart J. 2009.
PMID: 19586960
Clinical Trial.
Item in Clipboard
Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessments.
Bainey KR, Fu Y, Wagner GS, Goodman SG, Ross A, Granger CB, Van de Werf F, Armstrong PW; ASSENT 4 PCI Investigators.
Bainey KR, et al.
Am Heart J. 2008 Aug;156(2):248-55. doi: 10.1016/j.ahj.2008.03.018. Epub 2008 Jun 11.
Am Heart J. 2008.
PMID: 18657653
Clinical Trial.
Item in Clipboard
Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention Trial.
Jarai R, Huber K, Bogaerts K, Sinnaeve PR, Ezekowitz J, Ross AM, Zeymer U, Armstrong PW, Van de Werf FJ; ASSENT-4 PCI investigators.
Jarai R, et al.
Crit Care Med. 2010 Sep;38(9):1793-801. doi: 10.1097/CCM.0b013e3181eaaf2a.
Crit Care Med. 2010.
PMID: 20562693
Clinical Trial.
Item in Clipboard
Cite
Cite